ProMIS Neurosciences Inc. – Filings and Transcripts

NASDAQ: PMN
Share price (10/6/26): $9.21
Market cap (10/6/26): $82.6 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

Prospectuses and Registrations Filter

Registration of securities for employees

Shelf registration

Shelf registration

Shelf registration

Registration of securities for employees

Ownership Filter

Great Point Partners LLC

Wellington Biomedical Innovation Master Investors (Cayman) II L.P.

Wellington Management Group Llp

News Filter

Announces Second Quarter 2026 Financial Results and Provides Corporate Highlights

Reports Positive Blinded Six-Month Interim Safety and Biomarker Data for PMN310 in the PRECISE-AD Phase 1b Alzheimer’s Disease Trial

Change in Directors, Officers or Compensation, Shareholder Vote Results, Financial Statements or Exhibits

Announces First Quarter 2026 Financial Results and Provides Corporate Highlights

Announces Full Year 2025 Financial Results and Provides Corporate Highlights

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness